Literature DB >> 17068758

Classifications of ovarian cancer tissues by proteomic patterns.

Yi Zhu1, Rong Wu, Navneet Sangha, Chul Yoo, Kathleen R Cho, Kerby A Shedden, Hidetaka Katabuchi, David M Lubman.   

Abstract

Ovarian cancer is a morphologically and biologically heterogeneous disease. The identification of type-specific protein markers for ovarian cancer would provide the basis for more tailored treatments, as well as clues for understanding the molecular mechanisms governing cancer progression. In the present study, we used a novel approach to classify 24 ovarian cancer tissue samples based on the proteomic pattern of each sample. The method involved fractionation according to pI using chromatofocusing with analytical columns in the first dimension followed by separation of the proteins in each pI fraction using nonporous RP HPLC, which was coupled to an ESI-TOF mass analyzer for molecular weight (MW) analysis. A 2-D mass map of the protein content of each type of ovarian cancer tissue samples based upon pI versus intact protein MW was generated. Using this method, the clear cell and serous ovarian carcinoma samples were histologically distinguished by principal component analysis and clustering analysis based on their protein expression profiles and subtype-specific biomarker candidates of ovarian cancers were identified, which could be further investigated for future clinical study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068758     DOI: 10.1002/pmic.200600165

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  16 in total

1.  Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry.

Authors:  Paweena Kreunin; Chul Yoo; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  Cancer Genomics Proteomics       Date:  2007 Sep-Oct       Impact factor: 4.069

2.  Investigating the efficacy of nonlinear dimensionality reduction schemes in classifying gene and protein expression studies.

Authors:  George Lee; Carlos Rodriguez; Anant Madabhushi
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2008 Jul-Sep       Impact factor: 3.710

3.  Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

Authors:  Hyeyeung Kim; Rong Wu; Kathleen R Cho; Dafydd G Thomas; Gabrielle Gossner; J Rebecca Liu; Thomas J Giordano; Kerby A Shedden; David E Misek; David M Lubman
Journal:  Proteomics Clin Appl       Date:  2008-03-07       Impact factor: 3.494

4.  Histology image analysis for carcinoma detection and grading.

Authors:  Lei He; L Rodney Long; Sameer Antani; George R Thoma
Journal:  Comput Methods Programs Biomed       Date:  2012-03-20       Impact factor: 5.428

5.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

6.  Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.

Authors:  Yuan Tian; Zhihao Yao; Richard B S Roden; Hui Zhang
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

Review 7.  Proteomics of ovarian cancer: functional insights and clinical applications.

Authors:  Mohamed A Elzek; Karin D Rodland
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

Review 8.  Early detection of colon cancer: new tests on the horizon.

Authors:  Akshay K Gupta; Dean E Brenner; D Kim Turgeon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Janos L Tanyi; Rugang Zhang; Qin Liu; David W Speicher
Journal:  J Proteomics       Date:  2013-06-21       Impact factor: 4.044

Review 10.  David M. Lubman-The University of Michigan-A retrospective in research.

Authors:  David M Lubman
Journal:  Mass Spectrom Rev       Date:  2021-07-21       Impact factor: 10.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.